All Online

217 - 228 of 357 results

Refine

Active filters

1 CME CREDIT

Screening and Prevention Update: 2015

Presented Live at Pri-Med Midwest, October 2015

In this activity, Dr. Martin will review the latest guidelines as well as the rationale and controversies in screening and prevention. General principles and specific topics including colon, breast, cervical, lung and prostate cancer will be explored. Tips for counseling patients and selecting patients will also be reviewed. He will further discuss relevant vaccinations and cardiovascular screening.


0.5 CME CREDIT

Coronary artery calcium can be a valuable tool to measure cardiovascular risk and to inform the treatment of hyperlipidemia in appropriately selected individuals. Join Dr. Ty Gluckman as he discusses the history, predictive value, and most effective use of coronary artery calcium.


lady sitting on floor silhouette
0.5 CME CREDIT

Managing MDD With an Incomplete Treatment Response

An Interactive, Branching Patient Case

0.50 CME/MOC
0.50 AANP | 0.25 Pharmacology

Individuals with major depressive disorder (MDD) experiencing an incomplete response to initial antidepressant monotherapy can suffer functional impairment and poor clinical outcomes. The interactive, branching activity provides you with an opportunity to assess such a patient and make management decisions over multiple visits in a primary care setting. By the end of this complex case, you will be better equipped to recognize when a patient would benefit from treatment advancement and will understand the patient and pharmacologic factors involved in individualizing treatment escalation, including how and when to employ combination antidepressant therapy or augmentation with a second-generation antipsychotic agent.


Young lady holding her face down, really upset
0.5 CME CREDIT

MDD With a Partial Treatment Response—Candidates for Treatment Escalation (Module 1)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.46 AANP

This video-based resource activity will feature a dialogue between two expert faculty on the health, psychosocial, and functional burden of MDD on patients who experience an incomplete response to treatment. The discussion will emphasize the importance of prompt recognition of these individuals so that therapy advancement can occur at the earliest opportunity and will provide practical tools to help PCPs make this identification.


Upset young lady looking outside window on a rainy day
0.5 CME CREDIT

Advancing Antidepressant Therapy for Patients with MDD Who Have an Inadequate Treatment Response (Module 2)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.25 Pharmacology

In this video-based resource activity, expert faculty will discuss options for advancing antidepressant therapy in patients with an incomplete response to antidepressant monotherapy, including the neurochemical rationale for combining antidepressant therapy. It will also provide an approach for selecting antidepressant therapy in which the drugs’ clinical profiles correspond best to individual patient’s symptoms and other clinical factors.


Upset young man looking outside window with hand against window
0.5 CME CREDIT

What PCPs Should Know About Adjunctive Therapy for MDD (Module 3)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.32 Pharmacology

This video-based resource activity is designed to provide an overview of adjunctive therapy to treat patients with MDD who are experiencing a partial treatment response. These therapies include second-generation antipsychotic agents, esketamine, and non-pharmacologic modalities. Expert faculty will discuss the neurochemical rationale behind adjunctive treatment and differentiate between the various pharmacologic agents, with an emphasis on efficacy, adverse effects, and clinical profiles that can guide their use.


Pain management headline with stethoscope wrapping around
0.5 CME CREDIT

Opioid Use Disorder: Approaches to Diagnosis and Treatment

0.50 CME/MOC
0.50 AANP | 0.13 Pharmacology


Close up Young man suffering from shoulder pain
0.5 CME CREDIT

Prescribing opioids are not without risks. However, opioids continue to be prescribed for acute and chronic pain given that they have been shown to be an effective treatment for certain individuals. Consistent with all prescribed medications, it is important for the prescriber to be aware of common side effects and their management, as well as potential serious side effects and their management. These recommendations are designed to minimize harm to the patient, their loved ones/caregivers, as well as to inform the prescriber about best practices. This session will provide clinicians with an overview of general precautions necessary when prescribing opioids.


open bottle of pills spilt on table
0.5 CME CREDIT

Understanding Tolerance, Physical Dependence, and Addiction

0.50 CME/MOC
0.50 AANP | 0.50 Pharmacology